386 related articles for article (PubMed ID: 22710979)
1. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
[TBL] [Abstract][Full Text] [Related]
2. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
3. Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.
Goard CA; Mather RG; Vinepal B; Clendening JW; Martirosyan A; Boutros PC; Sharom FJ; Penn LZ
Int J Cancer; 2010 Dec; 127(12):2936-48. PubMed ID: 21351272
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
[TBL] [Abstract][Full Text] [Related]
5. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
7. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
12. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
[TBL] [Abstract][Full Text] [Related]
13. Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.
Bergstrom JD; Bostedor RG; Rew DJ; Geissler WM; Wright SD; Chao YS
Biochim Biophys Acta; 1998 Jan; 1389(3):213-21. PubMed ID: 9512650
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
Verhulst A; D'Haese PC; De Broe ME
J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974
[TBL] [Abstract][Full Text] [Related]
15. Toward a role for statins in immunomodulation.
Mach F
Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
[TBL] [Abstract][Full Text] [Related]
16. Class-specific pro-apoptotic effect of statins on human vascular endothelial cells.
Mück AO; Seeger H; Wallwiener D
Z Kardiol; 2004 May; 93(5):398-402. PubMed ID: 15160275
[TBL] [Abstract][Full Text] [Related]
17. Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study.
Leszczynska A; Gora M; Plochocka D; Hoser G; Szkopinska A; Koblowska M; Iwanicka-Nowicka R; Kotlinski M; Rawa K; Kiliszek M; Burzynska B
Acta Biochim Pol; 2011; 58(4):635-9. PubMed ID: 22132374
[TBL] [Abstract][Full Text] [Related]
18. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
20. Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.
Park WK; Kennedy RM; Larsen SD; Miller S; Roth BD; Song Y; Steinbaugh BA; Sun K; Tait BD; Kowala MC; Trivedi BK; Auerbach B; Askew V; Dillon L; Hanselman JC; Lin Z; Lu GH; Robertson A; Sekerke C
Bioorg Med Chem Lett; 2008 Feb; 18(3):1151-6. PubMed ID: 18155906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
